It is a link for moving within the page.

  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2010
  5. Streptococcus pneumoniae Kit "RAPIRUN S. pneumoniae" Approval obtained as in vitro diagnostic on May 26

May 31, 2010

Otsuka Pharmaceutical Co., Ltd.

Pharmaceuticals

Streptococcus pneumoniae Kit "RAPIRUN S. pneumoniae" Approval obtained as in vitro diagnostic on May 26

Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced that it obtained manufacturing and marketing approval of the Streptococcus pneumoniae antigen detection reagent by the immunochromatography method, "RAPIRUN S. pneumoniae" as an in vitro diagnostic on May 26, 2010.


Information in this news release was current as of the original release date.

Latest Pharmaceutical Business related News Releases

Most Recent Releases